Joana Goncalves, Chief Medical Officer at Oruka Therapeutics, Inc. (ORKA), sold 7,000 shares at $65.73 ($463K) on 2026-04-15, disclosed to the SEC on 2026-04-15.
Scheduled sale ($463k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.73 | 4,227 | $278K | 60.0% |
| 2 | $66.56 | 2,273 | $151K | 32.7% |
| 3 | $67.38 | 500 | $34K | 7.3% |
| Total | $66.12 avg | 7,000 | $463K | 100% |
| Filing → |
| ORKA | SELL | 2026-08-17 | $783K | — | Filing → |
| ORKA | SELL | 2026-07-15 | $604K | — | Filing → |
| ORKA | SELL | 2026-06-15 | $551K | — | Filing → |